Assuntos
Leucemia Neutrofílica Crônica , Reação Leucemoide , Neutrófilos , Humanos , Leucemia Neutrofílica Crônica/genética , Leucemia Neutrofílica Crônica/complicações , Reação Leucemoide/diagnóstico , Reação Leucemoide/patologia , Reação Leucemoide/etiologia , Neutrófilos/patologia , Masculino , Diagnóstico Diferencial , Feminino , Idoso , Pessoa de Meia-IdadeRESUMO
Antenatal screening/testing of pregnant women should be carried out according to the guidelines of the National Health Service (NHS) Sickle Cell and Thalassaemia Screening Programme. Newborn screening and, when necessary, follow-up testing and referral, should be carried out according to the guidelines of the NHS Sickle Cell and Thalassaemia Screening Programme. All babies under 1 year of age arriving in the United Kingdom should be offered screening for sickle cell disease (SCD). Preoperative screening for SCD should be carried out in patients from ethnic groups in which there is a significant prevalence of the condition. Emergency screening with a sickle solubility test must always be followed by definitive analysis. Laboratories performing antenatal screening should utilise methods that are capable of detecting significant variants and are capable of quantitating haemoglobins A2 and F at the cut-off points required by the national antenatal screening programme. The laboratory must ensure a provisional report is available for antenatal patients within three working days from sample receipt.
Assuntos
Anemia Falciforme , Hematologia , Hemoglobinopatias , Talassemia , Recém-Nascido , Feminino , Humanos , Gravidez , Medicina Estatal , Hemoglobinopatias/diagnóstico , Anemia Falciforme/diagnóstico , Anemia Falciforme/epidemiologia , Triagem Neonatal/métodos , Talassemia/diagnósticoRESUMO
The quantification of haemoglobin A2 by high-performance liquid chromatography (HPLC) was compared with quantification by capillary electrophoresis for control subjects and patients with sickle cell trait or sickle cell anaemia. Significant differences were found, with estimated values being higher by HPLC for control subjects and higher by capillary electrophoresis for sickle cell trait and sickle cell anaemia patients. There is an ongoing need for improved standardisation and alignment of methods.